Literature DB >> 17157481

Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002).

Jan A Patzer1, Danuta Dzierzanowska.   

Abstract

Analysis of the in vitro activity of imipenem and 13 other antibiotics against 2485 Pseudomonas aeruginosa isolates obtained from clinical specimens from children hospitalized during 1993-2002 was performed. In 2002, the percentage of P. aeruginosa isolates susceptible to all tested antibiotics, with the exception of imipenem, increased or remained on nearly the same level as in 1993. An increase of resistance to imipenem from 4.3% to 18.3% was observed. The MIC(90) value of imipenem increased from 2mg/L to 16 mg/L. Simultaneously, a four-fold increase of the usage of carbapenems imipenem and meropenem in the hospital was noted. In 2000-2001, a high incidence of imipenem-resistant strains was observed. The imipenem-resistant P. aeruginosa strains of serotype O6 from the general surgery ward and serotype O11 from the intensive care unit were shown to be clonally related by the pulsed-field gel electrophoresis method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157481     DOI: 10.1016/j.ijantimicag.2006.08.044

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Molecular analysis of the sequences surrounding blaOXA-45 reveals acquisition of this gene by Pseudomonas aeruginosa via a novel ISCR element, ISCR5.

Authors:  Hongyang Li; Timothy R Walsh; Mark A Toleman
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

2.  Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian Hospital.

Authors:  Siva Gowri Pathmanathan; Nor Azura Samat; Ramelah Mohamed
Journal:  Malays J Med Sci       Date:  2009-04

3.  Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  H Jamalifar; Hr Rahimi; N Samadi; Ar Shahverdi; Z Sharifian; F Hosseini; H Eslahi; Mr Fazeli
Journal:  Iran J Microbiol       Date:  2011-03

4.  Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.

Authors:  S Hammami; I Boutiba-Ben Boubaker; R Ghozzi; M Saidani; S Amine; S Ben Redjeb
Journal:  Diagn Pathol       Date:  2011-10-28       Impact factor: 2.644

5.  Metallo-beta-Lactamase VIM-1, SPM-1, and IMP-1 Genes Among Clinical Pseudomonas aeruginosa Species Isolated in Zahedan, Iran.

Authors:  Mehdi Ghamgosha; Shahram Shahrekizahedani; Farshid Kafilzadeh; Zakaria Bameri; Ramezan Ali Taheri; Gholamreza Farnoosh
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

6.  Molecular detection of metallo-β-lactamase gene blaVIM-1 in imipenem-resistant Pseudomonas aeruginosa strains isolated from hospitalized patients in the hospitals of Isfahan.

Authors:  Mansour Sedighi; Hamid Vaez; Mohsen Moghoofeie; Shima Hadifar; Golfam Oryan; Jamshid Faghri
Journal:  Adv Biomed Res       Date:  2015-02-23

Review 7.  Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.

Authors:  Thomas G Slama
Journal:  Crit Care       Date:  2008-10-29       Impact factor: 9.097

8.  Detection of blaPER-1 & blaOxa10 among imipenem resistant isolates of Pseudomonas aeruginosa isolated from burn patients hospitalized in Shiraz Burn Hospital.

Authors:  Amir Emami; Abdollah Bazargani; Ali Akbar Mohammadi; Mitra Zardosht; Seyed Morteza Seyed Jafari
Journal:  Iran J Microbiol       Date:  2015-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.